In the global analysis, RA patients had a higher frequency of CD14bright/CD56+ monocytes than healthy controls (12.2% ± 0.9 vs. 7.9% ± 0.5; P = 0.0002). This evidence concerns the gene NCAM1 and rheumatoid arthritis.